CORE 2021 – On-demand
Published: 16 June 2021
-
Views:
74816
-
Likes:
7
-
Views:
74816
-
Likes:
7
-
Up Next -
1h 31m 35s -
14m 21s
-
14m 23sPart 2 | Session 1 Welcome and EBC Updates on Left Main -
14m 37sPart 2 | Session 2 The DK Crush - Optimised -
1h 37m 35s -
13m 55sPart 2 | Session 4 Culotte – Optimised -
12m 57sPart 2 | Session 5 Recognising and Troubleshooting Bifurcation Complications -
19m 57sPart 2 | Session 6 CORE 2021 - Day 1 Wrap-up
-
15m 25sPart 3 | Session 1 Welcome and Defining Surgical 'Turndowns' -
13m 53sPart 3 | Session 2 Day Case PCI – How Can Imaging Help With Safe Discharge? -
18m 42sPart 3 | Session 3 The Role of an “Optimising” Procedure in Complex PCI -
17m 12sPart 3 | Session 4 Anticipating (& Preventing) Complications in CAC -
1h 31m 17sPart 3 | Session 5 LIVE CASES: Surgical Turndown Case and Calcium Modification Case
-
16m 18sPart 4 | Session 1 Access Site Management -
16m 39sPart 4 | Session 2 Modulating Radiation Risk, Stand Back or Stand Clear? -
19m 33sPart 4 | Session 3 Metabolic Dysregulation -
1h 19m 26s -
18m 8sPart 4 | Session 5 CORE 2021 – Day 2: Wrap-up
-
18m 32sPart 1 | Session 1 Welcome and Angina as a Therapeutic Goal – Redefining Success Evald Høj Christiansen, Thomas Engstrøm, Oskar Angeras, Lene Holmvang, Jonas Persson
-
14m 29sPart 1 | Session 2 Treating Angina: How to Leverage the Placebo Effect! Rasha Al-Lamee, Evald Høj Christiansen, Thomas Engstrøm, Oskar Angeras, Lene Holmvang, Jonas Persson
Overview
The 5th annual CORE meeting (16 and 17 June 2021) was hosted by Radcliffe Cardiology in collaboration with Optima Education and Abbott Vascular.
The meeting was led by Course Directors Prof Adrian Banning, Prof Evald Christiansen, Dr Jonathan Hill and Prof James Spratt and streamed from our London, Copenhagen, and Dublin hubs.
CORE 2021 focuses on contemporary standards of clinical practice, complex lesion and patient strategies and advanced diagnostic and treatment methods. The goal of CORE is to ensure procedural efficiencies while achieving durable patient outcomes, review patient care beyond intervention and discuss the best practices and innovation outside the catheterisation lab.
More from this programme
Part 1
CORE 2021 – Day 1: Morning – Physiology
Part 2
CORE 2021 – Day 1: Afternoon – Bifurcation Management
Part 3
CORE 2021 – Day 2: Morning – Durable Outcomes
Part 4
CORE 2021 – Day 2: Afternoon – Beyond Intervention
Faculty Biographies
Sarah Clarke
Consultant Cardiologist, Royal Papworth Hospital, Cambridge
Dr Sarah C Clarke is a Consultant Cardiologist and the Clinical Director for Strategic Development at Royal Papworth Hospital, Cambridge.
Adrian P Banning
Consultant Cardiologist
Prof Adrian Banning is a Consultant Cardiologist, specialising in percutaneous coronary intervention. He works as a Consultant in interventional and general cardiology and is one of the founder members of the Oxford Private Heart and Lung Centre at Nuffield Health Oxford at The Manor Hospital.
He is recognised as one of the UK’s top interventional cardiologists and until recently he was President of the British Cardiac Intervention Society. He performs more than 250 coronary intervention procedures every year and he is an expert in TAVI –implantation of a new aortic valve through a keyhole incision and performs >150 of these TAVI procedures each year.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.
Rasha Al-Lamee
Interventional Cardiology Consultant
Dr Rasha Al-Lamee is an interventional cardiology consultant at Imperial College Healthcare NHS Trust, London, UK.
Dr Al-Lamee studied at the University of Oxford and University College London. She completed her training in clinical cardiology on the north-west London cardiology rotation in 2013, and completed her PhD at Imperial College London in 2018.
Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is lead author of the primary publication in The Lancet. Dr Al-Lamee has more than 50 peer-reviewed publications and has presented at international cardiology conferences worldwide.
Peter O’Kane
Consultant Interventional Cardiologist
Dr Peter O'Kane has been Editor-in-Chief of Interventional Cardiology: Reviews, Research, Resources (ICR3) since July 2021.
Dr Peter O’Kane was appointed as a consultant interventional cardiologist at Royal Bournemouth Hospital in July 2007 and has performed more than 7000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification and chronic occlusions.
Dr O'Kane has given his permission to be contacted here.
Jonathan Hill
Dr Jonathan Hill qualified from Edinburgh University Medical School in 1992 following pre-clinical training at Cambridge University. He trained in cardiology at The London Chest and St Bartholomew's Hospitals.
In 1999 he was awarded the first National Heart, Lung and Blood Institute Bench to Bedside award and trained in basic science and interventional research within the Cardiovascular Branch of the National Institutes of Health in Bethesda. He completed his interventional cardiology training at the London Chest Hospital.
In 2005 he was appointed as Clinical Senior Lecturer and Consultant Cardiologist at King's College London.